What will Norway’s infliximab switching study tell us about the safety of switching patients from one biologic medicine to a biosimilar?
From the Blog
Heart Disease Deaths Climb in the UK
June 21, 2019
Rheumatoid Arthritis Patients Want Tools for Shared Medical Decision-Making
June 11, 2019